Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 10,680 | 7,199 | 6,681 | 6,873 | 7,304 |
| Cost of Goods | 3,643 | 2,887 | 3,660 | 3,921 | 3,830 |
| Gross Profit | 7,037 | 4,312 | 3,021 | 2,952 | 3,474 |
| Operating Expenses | 40,742 | 33,850 | 35,807 | 34,164 | 23,167 |
| Operating Income | -33,062 | -28,651 | -32,126 | -30,291 | -18,863 |
| Interest Expense | 0 | 0 | -3,744 | 303 | 2,714 |
| Other Income | 5,244 | 200 | 0 | 0 | 0 |
| Pre-tax Income | -27,818 | -28,451 | -28,382 | -30,594 | -21,577 |
| Income Tax | -2 | -128 | 287 | 105 | 45 |
| Net Income Continuous | -27,816 | -28,323 | -28,669 | -30,699 | -21,622 |
| Net Income | $-27,816 | $-28,323 | $-28,669 | $-30,699 | $-21,622 |
| EPS Basic Total Ops | -1.12 | -1.34 | -1.38 | -1.50 | -1.25 |
| EPS Basic Continuous Ops | -1.12 | -1.34 | -1.38 | -1.50 | -1.25 |
| EPS Diluted Total Ops | -1.12 | -1.34 | -1.38 | -1.50 | -1.25 |
| EPS Diluted Continuous Ops | -1.12 | -1.34 | -1.38 | -1.50 | -1.25 |
| EPS Diluted Before Non-Recurring Items | -1.12 | -1.35 | -1.38 | -1.50 | -1.25 |
| EBITDA(a) | $-32,126 | $-27,722 | $-30,522 | $-28,412 | $-17,325 |